APA 6th Edition Grce, M., Grahovac, B., Rukavina, T., Vrdoljak-Mozetič, D., Glavaš-Obrovac, Lj., Kaliterna, V. & Žele-Starčević, L. (2007). HPV Testing for Cervical Cancer Screening in Croatia. Collegium antropologicum, 31 - Supplement 2 (2), 67-71. Retrieved from https://hrcak.srce.hr/27447
MLA 8th Edition Grce, Magdalena, et al. "HPV Testing for Cervical Cancer Screening in Croatia." Collegium antropologicum, vol. 31 - Supplement 2, no. 2, 2007, pp. 67-71. https://hrcak.srce.hr/27447. Accessed 17 Oct. 2019.
Chicago 17th Edition Grce, Magdalena, Blaženka Grahovac, Tomislav Rukavina, Danijela Vrdoljak-Mozetič, Ljubica Glavaš-Obrovac, Vanja Kaliterna and Lidija Žele-Starčević. "HPV Testing for Cervical Cancer Screening in Croatia." Collegium antropologicum 31 - Supplement 2, no. 2 (2007): 67-71. https://hrcak.srce.hr/27447
Harvard Grce, M., et al. (2007). 'HPV Testing for Cervical Cancer Screening in Croatia', Collegium antropologicum, 31 - Supplement 2(2), pp. 67-71. Available at: https://hrcak.srce.hr/27447 (Accessed 17 October 2019)
Vancouver Grce M, Grahovac B, Rukavina T, Vrdoljak-Mozetič D, Glavaš-Obrovac Lj, Kaliterna V, et al. HPV Testing for Cervical Cancer Screening in Croatia. Collegium antropologicum [Internet]. 2007 [cited 2019 October 17];31 - Supplement 2(2):67-71. Available from: https://hrcak.srce.hr/27447
IEEE M. Grce, et al., "HPV Testing for Cervical Cancer Screening in Croatia", Collegium antropologicum, vol.31 - Supplement 2, no. 2, pp. 67-71, 2007. [Online]. Available: https://hrcak.srce.hr/27447. [Accessed: 17 October 2019]
Abstracts Opportunistic screening based on the Pap smear has been undertaken in Croatia since 1953. However, cervical cancer
remains an important health problem in Croatia when compared to European countries with organised screening programmes.
In Croatia, in addition to screening based on well established cytology, Human papillomavirus (HPV) testing
is widely used as secondary test as a triage to borderline cytology and as a follow-up after treatment of severe cervical
lesions. Many different approaches for HPV testing arose in Croatia over the last decade depending on the needs of each
medical institution involved. Presently, there is an urgent need for better networking between the laboratories, the implementation
of quality assessment and the adaptation of a uniform system of referring to and reporting of HPV testing. In
conclusion, the best possible organisation for HPV testing would be essential for implementation of HPV testing as primary
screening test in Croatia, an thus ultimately and hopefully, the more successful cervical cancer control.